(Washington, D.C., Monday, July 26, 2021)—Global Liver Institute (GLI) today urged the U.S. Food and Drug Administration to expedite the review of growing safety and effectiveness data and approve COVID-19 booster shots for organ transplant recipients and other immunocompromised individuals as soon as possible.
“Our population wants to be vaccinated,” Donna R. Cryer, JD, GLI CEO and president and a 26-year liver transplant recipient, wrote to Acting FDA Commissioner Janet Woodcock. “We desperately want to protect our weakened immune systems from a deadly virus and its pernicious variant. We are navigating living, working, and caring for our families, like everyone else. We, too, want to attend cook-outs and baseball games this summer. Please use your regulatory authority to help cancer, transplant, and other immunocompromised Americans safely rejoin society.”
